Hythiam, Inc. Announces Peer-Reviewed Publication of Randomized, Double-Blind, Placebo-Controlled Study
2/10/2010 9:52:56 AM
More...
|
Hythiam, Inc. CEO Interviewed on CorporateProfile.com
1/29/2010 12:03:32 PM
More...
|
Hythiam, Inc. Announces Publication on Predictive Modeling for Substance Dependent Populations in Perspectives in Health Information Management
1/13/2010 9:34:27 AM
More...
|
Hythiam, Inc. Announces First Peer-Reviewed Publication of Statistically Significant Results from Randomized, Double-Blind, Placebo-Controlled Study
9/28/2009 10:09:10 AM
More...
|
Hythiam, Inc. Announces Fourth Quarter and 2008 Year-End Results
4/1/2009 11:19:43 AM
More...
|
Hythiam, Inc. Announces Results of Two Double-Blind, Placebo-Controlled Studies on Impact of PROMETA(R) Treatment Program for Alcohol Dependence
3/26/2009 9:42:44 AM
More...
|
Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam, Inc.’s PROMETA(R) Treatment Program
11/18/2008 9:52:00 AM
More...
|
Double-Blind, Placebo-Controlled Alcohol Study of Hythiam, Inc.'s Prometa Treatment Program Demonstrated Statistically Significant Improvement in Patients with Symptoms of Alcohol Withdrawal
7/8/2008 9:15:08 AM
More...
|
Intent-to-Treat Analysis of Double-Blind Methamphetamine Study Confirms Hythiam, Inc.'s PROMETA Treatment Program Showed Statistically Significant Reduction in Cravings Compared to Placebo
6/19/2008 9:04:08 AM
More...
|
Russian Patent Office Provides Notification of Intention to Grant Hythiam, Inc. Patent for Treatment of Cocaine Dependence
11/5/2007 11:14:27 AM
More...
|
|